Grundlagen der medikamentösen Therapie

作者: Fotios Drakopanagiotakis , Andreas Günther

DOI: 10.1007/978-3-662-48419-7_5

关键词:

摘要: In diesem Kapitel werden verschiedene medikamentose Verfahren zur Behandlung seltener Lungenerkrankungen, mit Fokus auf die interstitiellen dargestellt. Die vorgeschlagenen Verabreichungswege und Dosierungen sowie Nebenwirkungen notwendige Kontrolluntersuchungen diskutiert.

参考文章(73)
Sirolimus for lymphangioleiomyomatosis lesions. The New England Journal of Medicine. ,vol. 358, pp. 1963- 1964 ,(2008) , 10.1056/NEJMC086040
Dirk Jan A.R. Moes, Henk-Jan Guchelaar, Johan W. de Fijter, Sirolimus and everolimus in kidney transplantation. Drug Discovery Today. ,vol. 20, pp. 1243- 1249 ,(2015) , 10.1016/J.DRUDIS.2015.05.006
Kenneth Nugent, Rishi Raj, Leflunomide-induced interstitial lung disease (a systematic review) Sarcoidosis Vasculitis and Diffuse Lung Diseases. ,vol. 30, pp. 167- 176 ,(2013)
Richard Conway, Candice Low, Robert J. Coughlan, Martin J. O'Donnell, John J. Carey, Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis & Rheumatism. ,vol. 66, pp. 803- 812 ,(2014) , 10.1002/ART.38322
Marta Morawska, Norbert Grzasko, Magdalena Kostyra, Jolanta Wojciechowicz, Marek Hus, Therapy‐related peripheral neuropathy in multiple myeloma patients Hematological Oncology. ,vol. 33, pp. 113- 119 ,(2015) , 10.1002/HON.2149
Kashif Raza, Jenna L. Scheffert, Immunosuppression in lung transplantation Journal of Thoracic Disease. ,vol. 6, pp. 1039- 1053 ,(2014) , 10.3978/J.ISSN.2072-1439.2014.04.23
Neil Vargesson, Thalidomide‐induced teratogenesis: History and mechanisms Birth Defects Research Part C-embryo Today-reviews. ,vol. 105, pp. 140- 156 ,(2015) , 10.1002/BDRC.21096
A. S.-F. Chong, L. Blinder, H. Gong, A. Finnegan, J. Shen, J. W. Williams, X. Xu, In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. Journal of Immunology. ,vol. 159, pp. 167- 174 ,(1997)
Marc A. Judson, The treatment of pulmonary sarcoidosis Respiratory Medicine. ,vol. 106, pp. 1351- 1361 ,(2012) , 10.1016/J.RMED.2012.01.013